Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.71 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.71 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | PGR | P06401 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 2/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | CRHBP | P24387 | 1/20 | 0.63 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.63 |
| ▸ | TGM2 | P21980 | 1/20 | 0.62 |
| ▸ | RNF4 | P78317 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diphenylether SCHEMBL27428436 | 0.94 | NAPRT (0.76) | HPGDSMN1; SMN2MTNR1AMTNR1BEPHX1 | |
| SCHEMBL6516221 | 0.92 | KMT2A (0.73) | HPGDSMN1; SMN2MTNR1AMTNR1BEPHX1 | |
| SCHEMBL18826484 | 0.86 | KMT2A (0.66) | HPGDSMN1; SMN2MTNR1AMTNR1BEPHX1 | |
| SCHEMBL9162294 | 0.86 | MTNR1B (0.77) | HPGDSMN1; SMN2MTNR1AMTNR1BEPHX1 | |
| SCHEMBL6304948 | 0.85 | MEN1 (0.59) | HPGDSMN1; SMN2MTNR1AMTNR1BEPHX1 | |
| SCHEMBL14384396 | 0.85 | MTNR1A (0.76) | SMN1; SMN2MTNR1AMTNR1BALDH1A1MAPT | |
| SCHEMBL14192610 | 0.85 | KMT2A (0.63) | HPGDSMN1; SMN2MTNR1AMTNR1BEPHX1 | |
| SCHEMBL5612841 | 0.85 | TDP1 (0.77) | HPGDSMN1; SMN2MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL2844063 | 0.85 | KMT2A (0.77) | HPGDSMN1; SMN2MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL8976234 | 0.84 | MTNR1A (0.65) | HPGDSMN1; SMN2MTNR1AMTNR1BEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919875-A2 | PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS | Astex Therapeutics Limited (GB) | 2008-05-14 | — | — | EP | claimed |
| WO-2007079003-A2 | AMIDE INHIBITORS OF LEUKOTRIENE A4 HYDROLASE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-07-12 | — | — | WO | claimed |
| WO-2006136829-A2 | PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-12-28 | — | — | WO | claimed |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | TAXIS PHARMACEUTICALS, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| US-20230157996-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF | Shenzhen Bay Laboratory (CN) | 2023-05-25 | — | — | US | disclosed |
| CN-110317322-B | Particulate amine-functionalized polyaryletherketone polymers and copolymers thereof | 塞特工业公司 | 2022-06-14 | — | — | CN | disclosed |
| EP-3145975-B1 | AMINE-DERIVATISED POLYARYLETHERKETONE COPOLYMERS | KETONEX LTD (GB) | 2021-03-17 | — | — | EP | disclosed |
| EP-3145980-B1 | PARTICULATE AMINE-FUNCTIONALIZED POLYARYLETHERKETONE POLYMER AND COPOLYMERS THEREOF | CYTEC IND INC (US) | 2020-04-08 | — | — | EP | disclosed |
| US-10450408-B2 | Method for making polyarylaliphaticetherketone polymers and copolymers thereof | KETONEX LIMITED (GB) | 2019-10-22 | — | — | US | disclosed |
| CN-110317322-A | Granular amine-functional polyaryl ether ketone polymer and its copolymer | 塞特工业公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-106661205-B | Particulate amine-functionalized polyaryletherketone polymers and copolymers thereof | 塞特工业公司 | 2019-08-06 | — | — | CN | disclosed |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION | 2007-04-05 | — | — | US | disclosed |
| US-20070060754-A1 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-03-15 | — | — | US | disclosed |
| US-20070060754-A1 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-03-15 | — | — | US | disclosed |
| WO-2006136829-A2 | PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-12-28 | — | — | WO | disclosed |
| US-5034410-A | Nitrile and oxo containing amides or thioamides | SYNTEX (U.S.A.) INC. (US) | 1991-07-23 | — | — | US | disclosed |
| EP-0023022-B1 | COUMARINE COMPOUNDS, PROCESSES FOR THEIR MANUFACTURE AS WELL AS THE INTERMEDIATE PRODUCTS USED PERSE AND THEIR UTILISATION FOR THE DYEING OR PRINTING OF TEXTILES | CIBA-GEIGY AG (CH) | 1984-04-11 | — | — | EP | disclosed |
| EP-0023022-A2 | Coumarine compounds, processes for their manufacture as well as the intermediate products used perse and their utilisation for the dyeing or printing of textiles | CIBA-GEIGY AG (CH) | 1981-01-28 | — | — | EP | disclosed |
| US-4072696-A | 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity | SYNTEX (U.S.A.) INC. (US) | 1978-02-07 | — | — | US | disclosed |
| US-3965113-A | 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity | SYNTEX (U.S.A.) INC. (US) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157996-A1 | SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF | SSB, EBNA1BP2, PML | HPGD 4591/4885SMN1; SMN2 2894/4885MTNR1A 3314/4885 |
| US-20070060754-A1 | Alkoxy substituted imidazoquinolines | IL2, IFNG, IRF3 | HPGD 538/4885SMN1; SMN2 3463/4885MTNR1A 1410/4885 |
| US-10450408-B2 | Method for making polyarylaliphaticetherketone polymers and copolymers thereof | DAO, DCXR, LOX | HPGD 898/4885SMN1; SMN2 4800/4885MTNR1A 3010/4885 |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | MAPK1, MAPK3, MAPK4 | HPGD 1529/4885SMN1; SMN2 2049/4885MTNR1A 194/4885 |
| US-20250179008-A1 | ANTIBACTERIAL AGENTS | ALK, ROS1, NOX1 | HPGD 3468/4885SMN1; SMN2 1208/4885MTNR1A 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.